We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.22B
AUM Growth
+$186M
Cap. Flow
+$231M
Cap. Flow %
10.43%
Top 10 Hldgs %
42.94%
Holding
2,313
New
704
Increased
422
Reduced
406
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 6.33%
2 Healthcare 5.48%
3 Consumer Discretionary 4.35%
4 Industrials 3%
5 Real Estate 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNW icon
1551
PUT
Genworth Financial
GNW
$3.71B
$5K ﹤0.01%
1,100
-5,000
-82% -$20.9K
INDP icon
1552
Indaptus Therapeutics
INDP
$157M
$5K ﹤0.01%
3
-27
-90% -$80.4K
LAB icon
1553
Standard BioTools
LAB
$314M
$5K ﹤0.01%
1,080
-25,167
-96% -$198K
PCG icon
1554
CALL
PG&E
PCG
$38.5B
$5K ﹤0.01%
+500
New +$7.56K
TDW icon
1555
Tidewater
TDW
$4.12B
$5K ﹤0.01%
360
-6,544
-95% -$123K
TEN
1556
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$5K ﹤0.01%
+400
New +$4.08K
GBT
1557
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5K ﹤0.01%
+100
New +$5.21K
XENT
1558
DELISTED
Intersect ENT, Inc
XENT
$5K ﹤0.01%
+270
New +$4.92K
RST
1559
DELISTED
ROSETTA STONE INC
RST
$5K ﹤0.01%
+300
New +$6.04K
I
1560
DELISTED
INTELSAT S. A.
I
$5K ﹤0.01%
+224
New +$4.73K
MDCO
1561
CALL
DELISTED
Medicines Co
MDCO
$5K ﹤0.01%
+100
New +$3.99K
HZNP
1562
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5K ﹤0.01%
+184
New +$4.76K
ADPT icon
1563
Adaptive Biotechnologies
ADPT
$3.97B
$4K ﹤0.01%
+143
New +$5.84K
BE icon
1564
Bloom Energy
BE
$64.6B
$4K ﹤0.01%
+1,080
New +$8.08K
DCO icon
1565
Ducommun
DCO
$2.98B
$4K ﹤0.01%
+100
New +$4.31K
DDOG icon
1566
Datadog
DDOG
$84B
$4K ﹤0.01%
+108
New +$3.75K
EXP icon
1567
Eagle Materials
EXP
$6.57B
$4K ﹤0.01%
43
-211
-83% -$18.1K
GOGO icon
1568
Gogo Inc
GOGO
$492M
$4K ﹤0.01%
713
-11,287
-94% -$53.2K
GRPN icon
1569
Groupon
GRPN
$1.02B
$4K ﹤0.01%
+73
New +$4.29K
KFY icon
1570
Korn Ferry
KFY
$4.28B
$4K ﹤0.01%
+100
New +$3.86K
NGS icon
1571
Natural Gas Services Group
NGS
$477M
$4K ﹤0.01%
+300
New +$4.11K
NX icon
1572
Quanex
NX
$1.01B
$4K ﹤0.01%
+200
New +$3.59K
OSPN icon
1573
OneSpan
OSPN
$618M
$4K ﹤0.01%
+300
New +$4.34K
PETS icon
1574
CALL
PetMed Express
PETS
$42.3M
$4K ﹤0.01%
200
UNF icon
1575
Unifirst Corp
UNF
$5.25B
$4K ﹤0.01%
+20
New +$3.88K

Similar funds

Prelude Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Prelude Capital Management held 2,313 positions worth $2.22B, up 9.1% from $2.03B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Prelude Capital Management deployed $231M of net new capital in Q3 2019, opening 704 new positions and adding to 422 existing holdings. Its largest new stake was Callon Petroleum Company: 418,579 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stewart Information Services, an estimated $7.45M trimmed.

  • Prelude Capital Management's largest Q3 2019 buy was Callon Petroleum Company: 418,579 shares worth $18.2M.
  • Prelude Capital Management added most to Altaba Inc in Q3 2019, an estimated $29.3M increase.
  • Prelude Capital Management's biggest Q3 2019 reduction was Stewart Information Services, cutting an estimated $7.45M.
  • Prelude Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $41.9M.
  • Prelude Capital Management's ten largest holdings make up 43% of its $2.22B portfolio in Q3 2019.
  • Prelude Capital Management opened 704 new positions and closed 646 in Q3 2019.
  • Prelude Capital Management's portfolio value rose 9.1% quarter-over-quarter to $2.22B.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.